Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Walaa Mohammedsaeed has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Dalal Binjawhar

    Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia

    3 shared publications
  • Dalal Nasser Binjawhar

    Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia

    3 shared publications
  • Fahad Alsehli

    Laboratory & Blood Bank Departments at King Salman Medical City, King Salman Medical City, Madinah, Saudi Arabia

    2 shared publications
  • Mohammed Alharbi

    Department of Speech and Language Disorders, Faculty of Medical Rehabilitation Sciences, Taibah University, Al-Madinah, Saudi Arabia

    2 shared publications
  • Nikhat Manzoor

    Medical Mycology Lab, Department of Biosciences, Jamia Millia Islamia, New Delhi, India

    2 shared publications
  • Abdullah Al Malki

    From the Department of Clinical Laboratory Sciences (Mohammedsaeed), Faculty of Applied Medical Science, Taibah University, and from the Department of Pathology and Laboratory Medicine (Al Malki, Alsayed), Prince Mohammed Bin Abdul-Aziz Hospital, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia

    1 shared publication

Latest Publications

  • Open Access

    Tumor Markers and Pancreatic Enzymes Reflect Early Pancreatic Dysfunction in Type 2 Diabetes

    by Walaa Mohammedsaeed, Suliman Alharbi, Lama Alraddadi, Saja Aljohani, Talat Almehmadi, Sarah Alawfi

    Objective: To evaluate whether pancreatic enzymes and tumor markers reflect early pancreatic dysfunction in patients with type 2 diabetes mellitus (T2DM). Methods: In this cross-sectional study conducted between January 2023 and January 2024, 300 Saudi adults with T2DM were assessed for serum CA19-9, CA125, amylase, and lipase. Associations with glycemic control, insulin resistance (homeostatic model assessment for insulin resistance [HOMA-IR]), and metabolic parameters were examined using multivariable linear and logistic regression adjusted for age, sex, body mass index, diabetes duration, lipid profile, and medication use. Receiver-operating characteristic analyses evaluated biomarker performance for identifying poor glycemic control (HbA1c >8.5%). Exploratory analyses assessed associations with recent acute pancreatitis. Results: Patients with poor glycemic control had significantly higher CA19-9 and CA125 levels and lower amylase and lipase levels (all p < 0.05). HbA1c and HOMA-IR remained independent predictors of tumor marker elevation and enzyme reduction after adjustment. Adjusted area under the curve values for detecting poor glycemic control were 0.81 for CA125, 0.79 for CA19-9, 0.75 for lipase, and 0.73 for amylase. A high-risk biomarker profile, defined as elevated CA19-9 or CA125 combined with low amylase or lipase, was associated with recent acute pancreatitis (adjusted odds ratio 2.3; 95% confidence interval 1.3–4.2). Conclusion: In T2DM, elevated tumor markers and reduced pancreatic enzyme activity are associated with poor glycemic control and insulin resistance and may indicate early pancreatic dysfunction. These biomarkers may aid risk stratification and warrant evaluation in prospective studies.

  • Open Access

    Anti-Thyroid Peroxidase Antibodies and Thyroid-Stimulating Hormone for Risk Stratification of Subclinical Thyroid Dysfunction in Patients With Type 2 Diabetes Mellitus

    by Walaa Mohammedsaeed, Samah Alfahl, Reham Aljohani, Amjad Alamri, Shahad Almutairi, Mai Almutairi

  • Open Access

    Latent autoimmune diabetes mellitus and its characteristics amongst adults diagnosed with type 2 diabetes at a single diabetes center in Medina, Saudi Arabia

    by Eman Alfadhli, Walaa Mohammedsaeed, Amal Surrati, Mashael Alharbi, Mansour Alharbi, Zain Alghamdi

    Background: To estimate the frequency and characteristics of Latent Autoimmune Diabetes in Adults (LADA) in patients diagnosed with type 2 diabetes mellitus (T2DM) at a single diabetes center in Medina, Saudi Arabia. Materials and Methods: This was a cross-sectional study involving patients with T2DM aged 30–70 years with a disease duration of ≤5 years, and who had not received insulin for at least 6 months post-T2DM diagnosis. Demographics, anthropometrics, autoantibodies to Glutamic Acid Decarboxylase Autoantibodies (GADA) and islet cell antibodies (ICA), serum C-peptide, glycated hemoglobin (HbA1C), and lipid data were collected. LADA was diagnosed according to GADA and/or ICA positivity. Participants were classified into two groups: LADA and non-LADA. The clinical and biochemical characteristics of both groups were compared. Results: A total of 157 participants (mean age 50 years, 52.9% male) were enrolled, with 30 (19.1%) testing positive for GADA and/or ICA. Among them, 16 (10.2%) were positive for GADA alone, 9 (5.7%) tested positive for ICA alone, and 5 (3.2%) tested positive for both GADA and ICA. GADA was significantly more prevalent in younger individuals (30–49 years, P = 0.02) and males, who also had higher rates of dual autoantibodies compared to females ( P = 0.03). LADA patients had a significantly shorter duration of diabetes, along with lower body mass index, C-peptide, and triglyceride levels, but exhibited higher HbA1c and greater insulin use. Conclusion: The study reveals a high rate of LADA within this cohort of Saudi patients diagnosed with T2DM. LADA patients display some clinical and biochemical characteristics that set them apart from conventional T2DM cases. Screening for β-cell autoantibodies in individuals with these features could aid in earlier diagnosis of LADA and allow for more tailored treatment approaches.

  • Open Access

    Lipid ratios as early screening markers of dyslipidemia in normal-BMI university students: a cross-sectional epidemiologic study

    by Samah Alfahl, Walaa Mohammedsaeed, Abdullah Alamri, Amira Elmihy, Fahad Almohmmadi, Roaa Alhejli, Rami Aljohani

    Introduction: This study aimed to determine the prevalence of dyslipidemia and to assess the predictive performance of lipid ratios, specifically the Atherogenic Index of Plasma (AIP) and the total cholesterol (TC) to high-density lipoprotein cholesterol (HDL-C) (TC/HDL) ratio, compared to body mass index (BMI) in identifying dyslipidemia among non-obese male university students. Material and methods: A cross-sectional study was conducted among 150 male students aged 20–30 years at a Saudi Arabian university. Participants underwent fasting lipid profiling, anthropometric measurements, and assessments of lifestyle behaviors including diet, physical activity, and smoking. Dyslipidemia was defined based on the NCEP-ATP III criteria. Predictive accuracy of AIP, TC/HDL ratio, and BMI was evaluated using receiver operating characteristic (ROC) curve analysis and logistic regression. Results: Dyslipidemia was detected in 60.7% of participants, despite a mean BMI of 25.3 ±4.0 kg/m², indicating that a substantial proportion of metabolically at-risk individuals were not obese. Unhealthy lifestyle behaviors were associated with an approximately eightfold increase in the odds of dyslipidemia (p < 0.001). Both AIP (AUC = 0.865) and TC/HDL ratio (AUC = 0.873) demonstrated significantly superior predictive performance compared with BMI (AUC = 0.570). More than 63% of students were classified as high-risk based on AIP levels. Cluster analysis revealed a distinct LDL–TG dominant phenotype strongly associated with unhealthy lifestyle factors. Conclusions: Lipid ratios, particularly AIP and TC/HDL, outperformed BMI in predicting early dyslipidemia among non-obese young adults. Incorporating these indices into routine screening could facilitate earlier detection of cardiovascular risk in university and preventive health settings, emphasizing the importance of targeted lifestyle interventions.


  • Open Access

    Cross-sectional analysis of the association between serum calcium levels and lipid profiles and the risk of cardiovascular disease in Saudi women

    by Walaa Mohammedsaeed, Amal Mohammed Q. Surrati, Asma Alshanqiti

    Calcium (Ca) plays a critical role beyond bone health, influencing lipid metabolism and cardiovascular risk. This study aimed to evaluate the association between serum Ca levels and lipid profiles among Saudi women, considering menopausal status. A cross-sectional study was conducted at Taibah University, Madinah, including 300 women aged 20 to 60 years. Participants were divided into premenopausal (n = 180) and postmenopausal (n = 120) groups. Fasting blood samples were collected to measure serum Ca, phosphorus, parathyroid hormone (PTH), vitamin D (Vit-D), and lipid profiles. Data were analyzed using analysis of variance and Pearson correlation. Postmenopausal women exhibited significantly higher levels of total cholesterol (TC), triglycerides (TG), Ca, and PTH, and lower HDL-C and Vit-D levels compared to premenopausal women ( P < .05). Serum Ca positively correlated with TC ( R = 0.643) and TG ( R = 0.731) and negatively with HDL-C ( r = –0.513) in postmenopausal women. A weaker but significant positive correlation between Ca and TC was observed in premenopausal women. Elevated serum Ca levels are associated with adverse lipid profiles, particularly in postmenopausal Saudi women, indicating an increased cardiovascular risk. Early screening and careful management of Ca and lipid levels are recommended to mitigate future cardiovascular complications.


  • Open Access

    The risk factors for cardiovascular disease and chronic kidney disease in patients with nonalcoholic fatty liver disease in Saudi Arabia

    by Walaa Mohammedsaeed, Abdullah Al Malki, Salma Alsayed

    Objectives: To identify potential risk factors for chronic kidney disease (CKD) and cardiovascular disease (CVD) in Saudi Arabian patients with non-alcoholic fatty liver disease (NAFLD). Methods: A 6-year prospective cohort study was carried out from January 2018 to January 2023, enrolling 1,500 patients. Data were initially collected between January 2018-2019, and follow-up assessments were carried out annually from 2020-2023. Patients were evaluated using biomarker analyses, and medical records were reviewed to assess the incidence of CVD and CKD. Biomarker levels, including blood creatinine, urine albumin, glomerular filtration rate (GFR), atherogenic index of plasma (AIP), and other key parameters, were monitored throughout the study. Results: Of the 1500 patients, 735 (49%) were diagnosed with NAFLD in 2018, while 765 (51%) did not have the condition. Compared to non-NAFLD patients, those with NAFLD exhibited elevated blood creatinine levels, lower GFR, and higher urine albumin, a key marker of kidney damage that is strongly linked to accelerated CKD progression and increased cardiovascular risk. Furthermore, NAFLD patients had a significantly higher AIP. Over the 4-year follow-up, these individuals showed a notable rise in the incidence of CKD and CVD. Conclusion: Non-alcoholic fatty liver disease is associated with alterations in lipid profiles, elevated high-sensitivity C-reactive protein (hs-CRP), and elevated aspartate aminotransferase (AST), all of which may contribute to early CKD and CVD development. Older, obese individuals with NAFLD, high triglyceride, AST, and hs-CRP levels are at an elevated risk for these diseases.


  • Open Access

    Interleukin 6: A Friend or Foe in Diabetic Nephropathy

    by Renad M. Alhamawi, Walaa Mohammedsaeed, Maha Aljumaa

    Introduction: This study aimed to investigate the relationship between serum cytokine levels, particularly Interleukin 6 (IL-6), and diabetic nephropathy (DN) in patients with type 1 (T1D) and type 2 diabetes (T2D).Material and methods: A cross-sectional study was conducted among 200 patients diagnosed with either T1D or T2D from January 2022 to December 2023 at the endocrinology and diabetes department of Madinah Hospital, Saudi Arabia.Results: A total of 200 individuals with type T1D (n=100) or T2D (n=100) were enrolled in this research. Male patients (54%) and those aged 30–50 (67.5%) dominated the cohort. About 50% had diabetes for less than 10 years, and 49.5% were overweight. 63.5% had reduced glomerular filtration rate, whereas 46% (n=92) had albuminuria. T1D patients were mostly normal weight, while T2D patients were overweight or obese. Both diabetes types had identical kidney damage stages. T1D patients are more likely to have moderately elevated albuminuria (53% vs. 37%, p <0.05) than T2D individuals. T1D patients had considerably lower serum cytokine levels than T2D patients. IL-6 levels were moderately correlated with fasting blood glucose (r = -0.318, p<0.01) and HbA1c (r= -0.319, p<0.01) in T1D patients. IL-6 had a modest correlation with renal dysfunction markers, including GFR and urine albumin-creatinine ratio (r= -0.250, p<0.05 and r= 0.338, p<0.001, respectively).Conclusions: Lower serum IL-6 levels in T1D patients are linked to delayed onset of kidney damage. The pro-inflammatory role of IL-6 may contribute to the development of diabetic nephropathy in T1D patients, as indicated by its association with albuminuria and renal function markers.


  • Biochemical Markers as Predictors of Health Outcomes in Autism Spectrum Disorder: A Comprehensive Systematic Review and Meta-analysis

    by Walaa Mohammedsaeed, Mohammed Alharbi

    Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with an increasing prevalence worldwide, including in Saudi Arabia. Emerging evidence suggests that biochemical markers, such as oxidative stress indicators, neurotransmitter levels, and lipid profiles, play a significant role in ASD’s pathology and may also elevate cardiovascular and metabolic risks in affected individuals. This systematic review and meta-analysis synthesize current findings on these biomarkers, with a particular focus on the Saudi population, to elucidate their relationship with ASD pathology and associated health outcomes. Following the PRISMA guidelines, data from 41 studies on oxidative stress markers, neurotransmitters, lipid profiles, and immune markers were analyzed. Searches were conducted across major databases, including PubMed, Scopus, Web of Science, and Embase, and effect sizes were calculated using standardized mean differences with a 95% confidence interval. To further interpret the data, bioinformatics tools such as Reactome, Panther, and STRING were employed to analyze biomarker pathways. The results highlight a significant association between elevated oxidative stress and mitochondrial dysfunction in individuals with ASD, with profound effects on gastrointestinal and mitochondrial health. These biochemical abnormalities disrupt synaptic plasticity and drive chronic neuroinflammation, which impairs neurodevelopmental processes, contributing to the pathology of ASD. The meta-analysis reveals minimal heterogeneity (I2 = 0.02%) and limited publication bias, supporting the reliability of these associations. The findings underscore the need for a multidisciplinary approach to ASD management in Saudi Arabia, emphasizing biomarker-based diagnostics and personalized treatment strategies. Future research directions include developing individualized diagnostic and therapeutic frameworks utilizing these biomarkers to enhance ASD-related health outcomes.